Inovio Pharmaceuticals
INO
#9592
Rank
HK$0.70 B
Marketcap
HK$8.54
Share price
-1.80%
Change (1 day)
-42.72%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.57. In 2024 the company made an earnings per share (EPS) of -HK$30.96 an increase over its 2023 EPS that were of -HK$47.73.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-27.5%
2024-HK$30.96-35.14%
2023-HK$47.73-56.62%
2022-HK$110.03-19.54%
2021-HK$136.7635.9%
2020-HK$100.63-11.57%
2019-HK$113.8015.24%
2018-HK$98.75-2.78%
2017-HK$101.576.93%
2016-HK$94.99134.88%
2015-HK$40.44-29.51%
2014-HK$57.37-57.34%
2013-HK$134.49146.55%
2012-HK$54.5520.83%
2011-HK$45.14-29.41%
2010-HK$63.95-48.48%
2009-HK$124.1410%
2008-HK$112.8611.11%
2007-HK$101.57-41.3%
2006-HK$173.05-66.91%
2005-HK$522.90110.61%
2004-HK$248.28-61.63%
2003-HK$647.04186.67%
2002-HK$225.71
2001N/A-100%
2000-HK$180.57-63.64%
1999-HK$496.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.47-403.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$55.02-343.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$10.27-145.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$53.68-337.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$27.88-223.52%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$30.46-234.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Arrowhead Pharmaceuticals
ARWR
HK$2.74-112.15%๐Ÿ‡บ๐Ÿ‡ธ USA